Why heart doctors will soon get fooled again

5 by / on 17 Nov 2015, / in statins

That old adage ‘Fool me once shame on you, fool me twice shame on me’ looks like a perfect description of why the heart disease establishment should be hanging its collective head. Having totally bought into one cholesterol-lowering class of drug – statins – it now looks ready to open its arms and pockets equally wide to embrace a new improved more powerful son of statin drug – the PCSK9 inhibitors – that will drive that deadly fatty stuff right to the floor.